JENNIFER PETERS: Open Payments
NPI 1568908879 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 31 payments from 9 companies in 2025. Trend: 2023 $332 · 2024 $389 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $178 |
| PFIZER INC. | 5 | $97 |
| CORDIS US CORP. | 3 | $81 |
| Medtronic, Inc. | 4 | $80 |
| Novo Nordisk Inc | 3 | $74 |
| Amgen Inc. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
Products named: ELIQUIS, MYNX CONTROL VENOUS, COREVALVE EVOLUT R, OPDUALAG, Wegovy, CAMZYOS, REPATHA, Kerendia.
Industry payments across NV — which companies pay providers there.
